Severance Hospital

Futó vizsgálatok

• Még nem toboroz

  Electrophysiological Dose-Response to Anterior Thalamic Deep Brain Stimulation in Drug-Resistant Focal Epilepsy

  NCT07912931· Forrás

• Toboroz

  Patient-Specific MRD Liquid Biopsy in Resected NSCLC: Plasma and Bronchial Washing ctDNA

  NCT07921888· Forrás

• Még nem toboroz

  Functional And STructural Assesment of the Heart by Artificial Intelligence-enabled Electrocardiogram for the Management of Atrial Fibrillation

  NCT07486739· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

  NCT07154745· 3. fázis· Forrás

• Toboroz

  Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

  NCT07486817· 2. fázis· Forrás

• Toboroz

  A Long-Term Follow-up Study of the Severe Parkinson's Disease Patients Administered the IPS101A Gene Therapy Product.

  NCT07629115· Forrás

• Toboroz

  Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

  NCT07524101· Forrás

• Toboroz

  A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

  NCT07481357· 1. fázis· Forrás

• Toboroz

  Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients

  NCT07371338· 1. fázis· Forrás

• Toboroz

  Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

  NCT07318597· 2. fázis· Forrás

• Még nem toboroz

  AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke

  NCT07491029· Forrás

• Toboroz

  DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  NCT07472517· 3. fázis· Forrás

• Toboroz

  A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

  NCT07423117· 1. fázis· Forrás

• Toboroz

  A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma

  NCT07010497· 2. fázis· Forrás

• Toboroz

  Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)

  NCT07359105· Forrás

• Toboroz

  An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma

  NCT07469683· 2. fázis· Forrás

• Toboroz

  Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma

  NCT07449754· 2. fázis· Forrás

• Toboroz

  A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor

  NCT07187401· 1/2. fázis· Forrás

• Toboroz

  A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer

  NCT07853209· 3. fázis· Forrás

• Toboroz

  Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

  NCT07195695· 3. fázis· Forrás

• Toboroz

  Pilot Clinical Trial to Assess the Safety of NMS-01 in Patients With Mild to Moderate Alzheimer's Disease

  NCT07869238· Forrás

• Toboroz

  A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

  NCT07222761· 3. fázis· Forrás

• Még nem toboroz

  Dronedarone Rhythm Intervention for Early Atrial Fibrillation

  NCT07270848· 4. fázis· Forrás

• Toboroz

  Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

  NCT06975787· 1. fázis· Forrás

• Toboroz

  A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

  NCT07128199· 3. fázis· Forrás

• Meghívásos bevonás

  The SMART Trial: Modified Single-Stapled Anastomosis in Laparoscopic or Robotic Low Anterior Resection for Rectal Cancer

  NCT07376980· Forrás

• Toboroz

  Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma

  NCT07235007· Forrás

• Még nem toboroz

  Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia

  NCT07247240· 4. fázis· Forrás

• Még nem toboroz

  Thickness Map-Guided vs. Empirical PV Isolation Using Pulsed Field Ablation for Paroxysmal AF

  NCT07068646· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Forrás

• Toboroz

  Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

  NCT07049926· 1/2. fázis· Forrás

• Fut, nem toboroz

  P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

  NCT06468033· 3. fázis· Forrás

• Még nem toboroz

  Effect of Bilateral vs. Unilateral Alveolar Recruitment on Gas Exchange in Lung Resection

  NCT07044661· Forrás

• Még nem toboroz

  A Phase 2 Study to Evaluate the Safety and Efficacy of BEY2153 in Patients with Early Alzheimer's Disease

  NCT06885567· 2. fázis· Forrás

• Toboroz

  Streamlining Radioembolization for CCC and Metastatic Liver Cancer

  NCT07043387· Forrás

• Toboroz

  Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy

  NCT06984952· Forrás

• Toboroz

  Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

  NCT06975410· 1/2. fázis· Forrás

• Toboroz

  Streamlining Radioembolization for Small HCC

  NCT06979219· Forrás

• Toboroz

  Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer

  NCT06873763· 1/2. fázis· Forrás

• Toboroz

  Efficacy and Safety Study of Isuzinaxib in Subjects With DKD

  NCT06962098· 2. fázis· Forrás

• Toboroz

  A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  NCT06935370· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone

  NCT06806852· 1. fázis· Forrás

• Még nem toboroz

  An Open-label, Single-arm, Multicenter Phase II Study to Evaluate the Efficacy of Amivantamab in Combination With FOLFIRI as a Second-line Treatment in Patients With RAS/BRAF Wild-type Advanced Colorectal Cancer Progressing on Prior Anti-EGFR Based Treatment.

  NCT06855849· 2. fázis· Forrás

• Toboroz

  A Multicenter Study of RUS NE

  NCT06868186· Forrás

• Toboroz

  Same-day Radioembolization for Large HCC

  NCT06944483· Forrás

• Toboroz

  Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation

  NCT06528262· 4. fázis· Forrás

• Toboroz

  Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria

  NCT06773845· 2. fázis· Forrás

• Toboroz

  A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

  NCT06687941· 1. fázis· Forrás

• Toboroz

  Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma

  NCT05439278· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák16 toboroz
• Máj- és epeúti rák13 toboroz
• Vastagbélrák8 toboroz
• Gyomor- és nyelőcsőrák7 toboroz
• Petefészekrák7 toboroz
• Gyermekkori daganatok6 toboroz
• 2-es típusú cukorbetegség5 toboroz
• Fej-nyaki daganatok5 toboroz
• Magas vérnyomás5 toboroz
• Pitvarfibrilláció5 toboroz
• Akut limfoid leukémia (ALL)4 toboroz
• Szívelégtelenség4 toboroz
• Hasnyálmirigyrák3 toboroz
• Krónikus vesebetegség3 toboroz
• Méhtestrák3 toboroz
• Tripla negatív emlőrák3 toboroz
• Vesedaganat3 toboroz
• Alzheimer-kór2 toboroz
• Áttétes emlőrák2 toboroz
• Hólyagrák2 toboroz
• Koszorúér-betegség2 toboroz
• Lupus (SLE)2 toboroz
• Méhnyakrák2 toboroz
• Melanóma2 toboroz
• Mielóma multiplex2 toboroz
• Neuroendokrin daganatok2 toboroz
• Parkinson-kór2 toboroz
• Prosztatarák2 toboroz
• Pulmonális artériás hipertónia2 toboroz
• Stroke (szélütés)2 toboroz
• Szarkóma2 toboroz
• Colitis ulcerosa1 toboroz
• Epilepszia1 toboroz
• Familiáris hiperkoleszterinémia1 toboroz
• Glioblasztóma1 toboroz
• Hepatitis B (krónikus)1 toboroz
• IgA-nefropátia1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Pajzsmirigyrák1 toboroz
• Rheumatoid arthritis1 toboroz
• Spinális izomatrófia (SMA)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  Streamlining Radioembolization for Intrahepatic Cholangiocarcinoma

  NCT07043348· Forrás

• Lezárult

  Feasibility of RUS Lung in MITS

  NCT06952894· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282

  NCT06747936· 3. fázis· Forrás

• Lezárult

  A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06335303· 2. fázis· Forrás

• Lezárult

  A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

  NCT06329141· 2. fázis· Forrás

• Leállították

  A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients

  NCT06186076· 1/2. fázis· Forrás

• Lezárult

  DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients

  NCT06406439· Forrás

• Lezárult

  A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor

  NCT06024408· 1. fázis· Forrás

• Lezárult

  A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

  NCT06066528· 3. fázis· Forrás

• Lezárult

  A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

  NCT06066515· 3. fázis· Forrás

• Lezárult

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· 3. fázis· Forrás

• Lezárult

  Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients

  NCT06144788· 2. fázis· Forrás

• Leállították

  GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer

  NCT05998447· 2. fázis· Forrás

• Lezárult

  Finding ED90 of Flumazenil for Selective Improvement of Respiratory Distress by Remimazolam

  NCT06563063· Forrás

• Leállították

  A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)

  NCT05660395· 1. fázis· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

  NCT05930028· 3. fázis· Forrás

• Lezárult

  Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia

  NCT05606094· Forrás

• Lezárult

  A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation

  NCT05804747· Forrás

• Lezárult

  Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

  NCT05718375· 2. fázis· Forrás

• Lezárult

  Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women

  NCT05630768· 4. fázis· Forrás

• Lezárult

  Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

  NCT05512377· 2. fázis· Forrás

• Lezárult

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· 3. fázis· Forrás

• Lezárult

  Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol

  NCT07564726· 3. fázis· Forrás

• Lezárult

  A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

  NCT04919512· 2. fázis· Forrás

• Leállították

  Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia

  NCT05079230· 3. fázis· Forrás

• Leállították

  Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular Carcinoma

  NCT05359861· 2. fázis· Forrás

• Lezárult

  A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

  NCT05002127· 2/3. fázis· Forrás

• Lezárult

  Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

  NCT05067634· 3. fázis· Forrás

• Lezárult

  A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)

  NCT05064059· 3. fázis· Forrás

• Leállították

  Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

  NCT04949256· 3. fázis· Forrás

• Lezárult

  Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) Admitted in ER

  NCT04996303· Forrás

• Lezárult

  Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

  NCT04903314· 1. fázis· Forrás

• Lezárult

  FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer

  NCT04768686· 2. fázis· Forrás

• Leállították

  Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment

  NCT04820023· 1/2. fázis· Forrás

• Lezárult

  Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

  NCT04484142· 2. fázis· Forrás

• Toboroz

  A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  NCT04710576· 2. fázis· Forrás

• Lezárult

  Shared Decision Making for Choosing renAl Replacement Therapy in Chronic Kidney Disease Patients

  NCT04976166· Forrás

• Lezárult

  KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B)

  NCT04165083· 2. fázis· Forrás

• Lezárult

  Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)

  NCT04626518· 1/2. fázis· Forrás

• Lezárult

  Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)

  NCT04626479· 1/2. fázis· Forrás

• Lezárult

  Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin

  NCT04387461· 2. fázis· Forrás

• Lezárult

  Effects of Iloprost on Pulmonary Oxygenation in Obese Patients During One-lung Ventilation

  NCT04583046· Forrás

• Lezárult

  Efocipegtrutide (HM15211) in Adults With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)

  NCT04505436· 2. fázis· Forrás

• Leállították

  A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

  NCT04338269· 3. fázis· Forrás

• Lezárult

  A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

  NCT04799496· Forrás

• Lezárult

  Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

  NCT04221945· 3. fázis· Forrás

• Lezárult

  Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

  NCT04374877· 1. fázis· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine

  NCT04289987· 2. fázis· Forrás

• Lezárult

  Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

  NCT04248829· 3. fázis· Forrás

• Lezárult

  Mid-Q Response Study

  NCT04180696· Forrás

Vizsgálati helyszínek

• Severance Hospital2 vizsgálat
• Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine1 vizsgálat
• Division of Pulmonology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine1 vizsgálat
• Severance hospital190 vizsgálat
• Severance Hospital; Division of Hematology1 vizsgálat
• Severance Hospital - Shinchon1 vizsgálat
• Severance Hospital (Site 0080)4 vizsgálat
• Severance Hospital (Site 0192)1 vizsgálat
• Severance Hospital (Site 0652)1 vizsgálat
• Severance Hospital (Site 1063)1 vizsgálat
• Severance Hospital (Site 1802)1 vizsgálat
• Severance Hospital (Site 3802)1 vizsgálat
• Severance Hospital (Site 5003)1 vizsgálat
• Severance Hospital (Site 5802)1 vizsgálat
• Severance Hospital, Yonsei1 vizsgálat
• Severance Hospital, Yonsei Uni2 vizsgálat
• Severance Hospital, Yonsei University College of Medicine2 vizsgálat
• SEVERANCE HOSPITAL, YONSEI UNIVERSITY (Site # 2702)1 vizsgálat
• Severance Hospital, Yonsei University (Site A)1 vizsgálat
• Severance Hospital, Yonsei University (Site B)1 vizsgálat
• Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center1 vizsgálat
• Yonsei University College of Medicine (Severance Hospital)3 vizsgálat
• Yonsei University, Severance Hospital (Seoul)1 vizsgálat
• Severance Hospital1 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Petefészekrák27 munka · 11 vizsgálat
• Migrén20 munka · 0 vizsgálat
• Pikkelysömör18 munka · 1 vizsgálat
• Idiopátiás tüdőfibrózis13 munka · 4 vizsgálat
• Méhtestrák13 munka · 7 vizsgálat
• Magas vérnyomás11 munka · 8 vizsgálat
• Neuromyelitis optica (NMOSD)6 munka · 0 vizsgálat